Q1 FY27 snapshot
Announcement Date31-Jul-26
Revenue (Top Line)₹16,024 Cr
Net Profit (Bottom Line)₹2,895 Cr
Earnings Per Share (EPS)₹12.06
Expenses₹13,129 Cr
Net profit margin (calculated)18.1%
Sun Pharmaceutical Industries Ltd. (SUNPHARMA) Quarterly Results: Q1 FY27
Quick answer: Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) reported Q1 FY27 revenue of ₹16,024 Cr and net profit of ₹2,895 Cr, with earnings per share (EPS) of ₹12.06, announced on 31-Jul-26.
That works out to a net profit margin of about 18.1% for the quarter.
Note: figures are pulled automatically from company filings and may lag or contain gaps. Verify on NSE or BSE. Not investment advice.
How to read Sun Pharmaceutical Industries Ltd.'s Q1 FY27 results
Revenue of ₹16,024 Cr is what Sun Pharmaceutical Industries Ltd. earned before costs. Net profit of ₹2,895 Cr is what remained for shareholders after expenses, interest and tax. Dividing one by the other gives a net margin of about 18.1%, a quick gauge of how much of each rupee of sales is kept as profit.
New to results? Read our guide on how to read quarterly results, see the full results list or the dividend calendar.
FAQs
Sun Pharmaceutical Industries Ltd. results FAQs
What were Sun Pharmaceutical Industries Ltd.'s Q1 FY27 results?
Sun Pharmaceutical Industries Ltd. (NSE: SUNPHARMA) reported Q1 FY27 revenue of ₹16,024 Cr and net profit of ₹2,895 Cr, with earnings per share (EPS) of ₹12.06, announced on 31-Jul-26.
What is Sun Pharmaceutical Industries Ltd.'s EPS for Q1 FY27?
Sun Pharmaceutical Industries Ltd.'s earnings per share for Q1 FY27 was ₹12.06. EPS is net profit divided by the number of outstanding shares.
When did Sun Pharmaceutical Industries Ltd. announce its Q1 FY27 results?
Sun Pharmaceutical Industries Ltd. announced its Q1 FY27 results on 31-Jul-26.
What is Sun Pharmaceutical Industries Ltd.'s net profit margin?
On the reported figures, Sun Pharmaceutical Industries Ltd.'s Q1 FY27 net profit margin is about 18.1% (net profit ÷ revenue).